Dr. Khan Patail is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
207 Foote Ave
Jamestown, NY 14701Phone+1 716-485-7472
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2015 - 2018
St. George's University School of MedicineClass of 2014
Certifications & Licensure
CA State Medical License 2016 - Present
NY State Medical License 2017 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsAttenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate TumorsGoutam Chakraborty, Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu
Clinical Cancer Research. 2021-03-15 - 21 citationsRibonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.Ying Z. Mazzu, Joshua Armenia, Subhiksha Nandakumar, Goutam Chakraborty, Yuki Yoshikawa
Molecular Oncology. 2020-08-01 - 69 citationsSignificance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression.Goutam Chakraborty, Joshua Armenia, Ying Z. Mazzu, Subhiksha Nandakumar, Konrad H. Stopsack
Clinical Cancer Research. 2020-04-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
